Financial insights of BIO-B

MyFinsight

For the year ending 2025-12-31, BIO-B made $2,583,200K in revenue. $759,900K in net income. Net profit margin of 29.42%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-12-31
Net sales	2,583,200
Cost of goods sold	1,243,300
Gross profit	1,339,900
Selling, general and administrative expense	844,300
Research and development expense	275,600
Impairment of purchased intangibles and related items, net	172,800
Income from operations	47,200
Interest expense	49,000
Foreign currency exchange gains, net	6,600
(gains) losses from change in fair market value of equity securities and loan receivable	900,400
Other income, net	90,300
Net income (loss) before income taxes	995,500
(provision for) benefit from income taxes	235,600
Net income (loss)	759,900

Net income (loss) per basic share (in dollars per share)	27.87
Net income (loss) per diluted share (in dollars per share)	27.85
Weighted average common shares - basic (in shares)	27,263,000
Weighted average common shares - diluted (in shares)	27,281,000